LUNA INNOVATIONS INCORPORATED — Department of Defense SBIR Phase II: SB153-001

Description

Breakthroughs in the development of neural interface technologies have been prevelent over the last decade, in large part due to the success of DARPA-funded. These advancements have included state-of-the-art prosthetics controlled by neural interfaces as well as implementation of sensitization using interfaced prosthetics. While these treatments continue to improve and have achieved moderate success, existing technologies lack the long-term stability and precision that will be required for clinical translation. The two primary limiting complications with existing neural interface technologies are tissue damage and mechanical failure of the device. The 5-6 order of magnitude discrepancy in elastic modulus leads to a variety of implantation and chronic use issues such as tissue damage, difficult surgical attachment, and relative motion during use. Luna Innovations is therefore developing a unique nanofiber-based material system known as bioCXN™. This exciting material technology is being proposed for use with the TIME interface design, but will also be applicable to many other existing neural interface technologies in the future.